Overview

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult Volunteers

Status:
COMPLETED
Trial end date:
2024-03-28
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to compare the pharmacokinetics and the safety between a fixed-dose combination administration of "BR3005" and co-administration of "BR3005-1" and "BR3005-2" under fasting conditions in healthy adult volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd